evalu
safeti
immunogen
chimer
alphaviru
vaccin
candid
mice
select
immunodefici
vaccin
candid
highli
attenu
mice
defici
b
cell
compart
well
mice
defici
gammainterferon
respons
howev
level
protect
vari
among
strain
test
wild
type
mice
protect
lethal
veev
challeng
contrast
alphabeta
tcrdefici
mice
develop
lethal
enceph
follow
veev
challeng
mice
defici
gammadelta
cell
protect
surprisingli
vaccin
potenc
diminish
anim
lack
interferongamma
receptor
alpha
chain
chain
minor
vaccin
immunoglobulin
heavi
chaindefici
mice
surviv
challeng
suggest
neutral
antibodi
may
absolut
requir
protect
prolong
replic
encephalit
veev
brain
preimmun
mice
lethal
adopt
transfer
experi
indic
cell
requir
protect
develop
safe
attenu
vaccin
drug
therapi
central
nervou
system
cn
invad
virus
critic
elucid
mechan
pathogen
clearanc
host
surviv
pathogenesi
result
viral
enceph
mediat
emerg
biothreat
zoonot
pathogen
sever
alphavirus
name
eastern
western
venezuelan
equin
enceph
virus
etiolog
agent
enceph
highli
lethal
human
experiment
anim
model
weaver
encephalit
alphavirus
known
replic
high
titer
mice
invas
cn
occur
rapidli
anim
infect
via
intranas
rout
lead
acut
lethal
enceph
paessler
et
al
paessler
et
al
alphaviru
venezuelan
equin
enceph
viru
veev
zoonot
pathogen
multipl
subtyp
respons
signific
morbid
mortal
epizoot
outbreak
equin
human
weaver
et
al
recent
outbreak
south
america
approxim
human
case
infect
report
clinic
case
diagnos
weaver
et
al
casefat
rate
equin
speci
rel
high
reach
level
exceed
primarili
due
spread
infect
cn
result
enceph
human
mortal
rate
rel
low
b
clinic
sign
neurolog
diseas
preval
especi
children
de
la
mont
et
al
weaver
et
al
variou
anim
model
use
examin
distinct
phase
infect
includ
develop
veevinduc
enceph
hamster
mous
model
use
understand
pathogenesi
viru
host
immun
respons
well
evalu
vaccin
charl
et
virolog
wwwelseviercomlocateyviro
al
ryzhikov
et
al
ryzhikov
et
al
infect
mous
peripher
rout
challeng
exposur
subcutan
result
biphas
diseas
pattern
viru
initi
replic
lymphoid
tissu
ultim
progress
cn
anishchenko
et
al
paessler
et
al
paessler
et
al
intranas
intracrani
challeng
result
earlier
cn
penetr
cn
infect
establish
anim
acut
meningoenceph
neuron
cell
death
follow
uniformli
fatal
charl
et
al
ryzhikov
et
al
ryzhikov
et
al
infect
brain
associ
develop
inflammatori
respons
immunocompet
host
perivascular
vascular
infiltr
mononuclear
cell
edema
microhemorrhag
patholog
associ
infect
dissemin
throughout
brain
except
promin
focal
respons
cortex
immunohistochem
analysi
distribut
viral
antigen
cn
indic
stain
neuron
neuropil
well
astrocyt
anishchenko
et
al
paessler
et
al
veev
potenti
biothreat
agent
thu
vaccin
limit
infect
andor
fatal
enceph
current
develop
use
varieti
approach
charl
et
al
davi
et
al
paessler
et
al
live
attenu
vaccin
strain
develop
four
decad
ago
serial
passag
trinidad
donkey
trd
veev
strain
guinea
pig
myocyt
remain
avail
vaccin
human
howev
residu
pathogen
concern
strain
anishchenko
et
al
jahrl
scherer
paessler
et
al
recent
new
gener
liveattenu
vaccin
incorpor
use
alphaviru
vector
express
veev
protein
shown
safe
effect
protect
mice
hamster
lethal
diseas
paessler
et
al
paessler
et
al
use
rel
rigor
challeng
veev
strain
via
intracerebr
intranas
rout
mice
protect
lethal
enceph
follow
vaccin
vaccin
mice
develop
overt
sign
diseas
reduc
level
viral
replic
moreov
vaccin
nih
swiss
outbr
mice
develop
strong
antiveev
neuroinflammatori
respons
upon
challeng
wild
type
viru
high
titer
serumneutr
antibodi
paessler
et
al
paessler
et
al
despit
initi
character
respons
vaccin
mice
protect
challeng
dose
would
uniformli
lethal
unvaccin
anim
precis
basi
adapt
immun
respons
stimul
sindbisveev
chimera
ultim
lead
protect
fulli
character
evalu
safeti
recent
describ
liveattenu
vaccin
candid
cellular
basi
protect
follow
vaccin
protect
immunocompet
wild
type
mice
acut
lethal
enceph
paessler
et
al
paessler
et
al
util
inbr
mice
select
immunodefici
cell
compart
tcrdefici
tcrdefici
mice
itohara
et
al
mombaert
et
al
b
cell
compart
mice
kitamura
et
al
abil
respond
cytokin
interferon
gamma
mice
huang
et
al
seri
studi
preliminari
veev
infect
studi
immunodefici
mous
strain
succumb
diseas
day
follow
infect
immunocompet
wild
type
mice
data
shown
indic
immunodefici
mice
differ
significantli
suscept
veev
therefor
use
immunizationchalleng
model
examin
differ
immun
effector
mechan
link
activ
antigenpres
cell
cn
arm
effector
activ
innat
adapt
effector
antivir
pathway
binder
griffin
burdeinickkerr
griffin
owen
et
al
alphabeta
cell
repres
major
peptidespecif
cell
wherea
cell
hypothes
form
link
innat
adapt
immun
howev
mani
function
cell
unknown
particularli
central
nervou
system
born
et
al
protect
lethal
enceph
depend
presenc
cell
receptor
tcr
bear
cell
tcrbear
cell
remark
tcrdefici
mice
protect
lethal
viral
challeng
intranas
inocul
veev
continu
persist
variant
challeng
strain
found
day
follow
challeng
data
unambigu
demonstr
distinct
role
murin
cell
vaccin
challeng
respons
neurovirul
veev
chimer
viru
attenu
mice
select
immun
defici
tcr
tcr
mice
surviv
vaccin
none
anim
show
sign
diseas
period
day
follow
vaccin
mice
surviv
vaccin
one
three
replic
experi
two
mice
suddenli
die
without
previou
sign
typic
vee
anorexia
andor
paralysi
anim
appear
healthi
throughout
vaccin
period
fig
unabl
recov
infecti
viru
brain
two
anim
die
know
precis
caus
death
howev
observ
health
statu
mice
prior
manipul
equival
immunodefici
strain
therefor
may
explain
result
major
mice
febril
hypotherm
respons
vaccin
evid
daili
telemetr
bodi
measur
vaccin
anim
fig
posit
control
veevinfectioninduc
chang
bodi
temperatur
leukopenia
infect
unvaccin
tcrdefici
mice
veev
mice
infect
virul
veev
febril
respons
occur
day
infect
follow
develop
hypothermia
day
among
mice
short
period
increas
bodi
temperatur
occur
day
anim
addit
hematolog
evalu
indic
chang
whitebloodcel
count
occur
vaccin
anim
veevinfect
mice
leukopenia
occur
day
infect
data
shown
sindbisveev
vaccin
candid
induc
protect
diseas
anim
select
immunodefici
except
mice
develop
detect
diseas
vaccin
indic
recombin
genet
approach
offer
highli
attenu
vaccin
candid
mous
model
addit
previous
demonstr
attenu
vaccin
candid
highli
immunogen
paessler
et
al
strain
veev
uniformli
lethal
naiv
mice
nih
swiss
strain
day
inocul
plaqu
form
unit
pfu
lethal
dose
ld
via
intranas
rout
subsequ
vaccin
studi
util
chimer
sinzpc
viru
mice
surviv
lethal
challeng
regimen
unlik
mock
vaccin
control
mice
paessler
et
al
prompt
us
examin
effector
mechan
chimer
alphaviru
vaccin
elicit
provid
protect
lethal
enceph
caus
veev
studi
util
similar
vaccinationchalleng
regimen
immun
parent
wild
type
wt
immunodefici
mice
chimer
alphavirusve
viru
sinzpc
challeng
mice
virul
veev
ca
ld
assess
surviv
period
addit
evalu
histopatholog
inflammatori
respons
viral
replic
brain
peripher
tissu
lung
liver
spleen
vaccin
mice
follow
challeng
surviv
curv
two
immun
sinzpc
subsequ
veev
challeng
present
fig
proport
tcrdefici
mice
surviv
observ
period
replic
ident
mockvaccin
wt
mice
replic
contrast
proport
survivor
among
vaccin
tcrdefici
mice
high
independ
replic
significantli
greater
p
vaccin
wt
mice
independ
replic
surviv
ko
mice
reduc
independ
replic
compar
vaccin
wt
tcr
ko
mice
major
mice
surviv
challeng
independ
replic
statist
signific
differ
surviv
proport
vaccin
mice
mock
vaccin
wt
mice
p
fig
vaccin
safeti
studi
mice
surviv
averag
bodi
temperatur
wild
type
immunodefici
mice
vaccin
liveattenu
chimer
alphaviru
vaccin
sinzpc
panel
b
show
surviv
averag
bodi
temperatur
parent
wild
type
wt
immunodefici
mice
inocul
liveattenu
chimer
alphaviru
vaccin
sinzpc
panel
c
show
averag
bodi
temperatur
follow
veev
infect
unvaccin
mice
total
percentag
surviv
mice
averag
bodi
temperatur
b
sinzpc
vaccin
ko
tcr
ko
ko
wt
mice
vaccin
day
evalu
follow
vaccin
eleven
femal
mice
inocul
day
day
subcutan
medial
thigh
chimer
sin
zpc
viru
dose
plaqu
form
unit
total
volum
mockvaccin
mice
indic
wt
unvacc
inocul
subcutan
pb
viru
challeng
sinzpc
mockvaccin
mice
inocul
day
intranas
ident
dose
virul
veev
pb
death
record
daili
telemetr
monitor
bodi
temperatur
perform
total
period
day
begin
day
prior
first
vaccin
day
asterisk
indic
parent
mice
wild
type
wt
characterist
parent
wt
immunodefici
mice
describ
materi
method
tabl
c
posit
control
telemetr
monitor
bodi
temperatur
unvaccin
tcr
ko
mice
day
day
day
day
infect
virul
veev
day
median
surviv
time
follow
challeng
vaccin
cell
defici
vaccin
mice
similar
mockvaccin
wt
mice
day
respect
howev
none
vaccin
tcr
defici
mice
surviv
beyond
day
postinfect
fig
ko
mice
also
surviv
longer
period
time
death
occur
day
compar
day
day
mockvaccin
wild
type
tcrdefici
mice
respect
viru
titer
evalu
brain
peripher
organ
vaccin
challeng
immunodefici
mice
fig
day
postchalleng
viral
titer
brain
peripher
tissu
wild
type
vaccin
mice
uniformli
low
b
pfug
day
postchalleng
undetect
contrast
mockvaccin
wild
type
mice
high
titer
detect
pfug
fig
anim
select
immun
defici
vaccin
high
level
infecti
viru
detect
tissu
either
day
day
highest
titer
brain
day
postchalleng
fig
parent
wt
tcrdefici
mice
develop
hind
limb
paralysi
prior
death
indic
black
bar
fig
hallmark
diseas
develop
veevinfect
mice
statist
analysi
compar
differ
viral
titer
group
indic
despit
appear
higher
averag
viral
titer
liver
dpi
tcrdefici
mice
differ
statist
signific
kruskalw
test
p
tabl
also
evalu
rel
degre
inflamm
necrosi
fig
viral
antigen
level
fig
brain
vaccin
challeng
mice
day
day
postinfect
semiquantit
analysi
histopatholog
immunohistochemistri
result
present
tabl
day
postinfect
tcrdefici
mice
exhibit
inflammatori
respons
compar
group
vaccin
immunodefici
mous
strain
test
addit
slightli
extens
tissu
necrosi
compar
mockvaccin
wt
control
mice
tcrdefici
mice
extent
inflamm
necrosi
intermedi
level
rel
mock
vaccin
wt
vaccin
tcrdefici
mice
tabl
agreement
viral
titer
present
fig
rel
level
local
viral
antigen
variou
area
brain
identifi
immunohistochemistri
differ
extens
among
treatment
group
fig
tabl
earli
infect
day
post
challeng
viral
antigen
detect
olfactori
bulb
brain
stem
anim
except
previous
vaccin
wt
mice
fig
day
post
challeng
almost
part
brain
posit
viru
antigen
immunodefici
mice
mock
vaccin
wt
mice
strong
stain
viral
antigen
detect
hippocampu
brain
stem
well
cortex
fig
cerebellum
perform
histopatholog
immunohistochemistri
studi
fig
determin
whether
correl
exist
presenc
viral
antigen
type
lymphocyt
enter
brain
protect
vaccin
anim
day
postchalleng
detect
histopatholog
enceph
focal
infiltr
posit
cell
tcrdefici
mice
fig
tcrdefici
mice
fig
detect
rel
high
proport
cell
brain
tcrdefici
mice
day
postchalleng
fig
contrast
immunocompet
mice
cell
brain
mice
cell
could
detect
time
data
shown
vaccin
tcrdefici
mice
enceph
evid
histolog
section
brain
day
postchalleng
fig
absenc
posit
cell
fig
cell
abund
brain
tcrdefici
mice
fig
similar
level
cell
demonstr
day
asymptomat
tcrdefici
mice
fig
level
strongli
reduc
day
data
shown
wt
mice
previous
vaccin
develop
rel
modest
inflammatori
respons
fig
contrast
mockvaccin
encephalit
anim
brain
section
stain
intens
cell
day
postinfect
fig
humor
immun
respons
assess
use
plaqu
reduct
neutral
test
prnt
reduct
fig
vaccin
efficaci
mous
model
surviv
sinzpc
doublevaccin
wild
type
immunodefici
mice
follow
challeng
virul
veev
sixweekold
femal
parent
wild
type
wt
immunodefici
mice
vaccin
day
day
subcutan
medial
thigh
chimer
sinzpc
vaccin
dose
plaqu
form
unit
pfu
total
volum
pb
pb
alon
wt
unvacc
death
record
follow
intranas
challeng
virul
veev
dose
pfu
per
anim
ca
ld
pb
week
follow
initi
vaccin
asterisk
indic
parent
mice
wild
type
wt
characterist
immunodefici
mice
describ
materi
method
tabl
total
percentag
surviv
mice
b
number
surviv
mice
replic
experi
comparison
surviv
curv
use
logrank
test
altman
indic
statist
signific
differ
surviv
overal
experiment
group
monitor
period
logrank
p
b
fisher
exact
test
use
compar
surviv
proport
vaccin
strain
mock
vaccin
wt
individu
pvalu
indic
surviv
curv
determin
level
veevneutr
antibodi
serum
vaccin
mice
parent
wt
immunodefici
preand
postchalleng
tabl
prnt
titer
sinzpc
vaccin
wt
mice
posit
major
vaccin
tcrdefici
mice
neg
develop
detect
level
neutral
antibodi
end
studi
day
challeng
overal
titer
slightli
reduc
major
posit
serum
sampl
obtain
tcrdefici
mice
rel
wt
mice
rang
neutral
antibodi
titer
tcrdefici
mice
posit
uniformli
limit
detect
titer
b
minor
proport
ko
mice
develop
detect
level
neutral
antibodi
posit
exclud
possibl
persist
effector
cell
respons
protect
tcrdefici
mice
perform
addit
experi
mice
challeng
month
singl
vaccin
fig
mice
fulli
protect
lethal
outcom
surviv
determin
cell
directli
mediat
protect
adopt
transfer
experi
perform
use
veevspecif
cell
obtain
vaccin
donor
mice
experi
design
test
restor
protect
adopt
transfer
cell
spleen
wt
donor
mice
vaccin
chimer
sinzpc
fig
puriti
isol
cell
assess
via
flow
cytometr
analysi
cell
immunostain
antibodi
tabl
anim
sacrif
day
b
day
postchalleng
organ
harvest
viral
titrat
limit
detect
pfug
indic
solid
line
adopt
transfer
experi
shown
fig
c
data
shown
transfer
splenic
cell
vaccin
donor
tcrdefici
mice
result
restor
protect
lethal
enceph
control
mock
mice
protect
result
suggest
primari
protect
cell
type
elicit
vaccin
chimer
sinzpc
experiment
vaccin
resid
within
cell
popul
infecti
viru
could
recov
brain
persist
infect
defici
mice
either
via
cell
cultur
inocul
brain
homogen
altern
intracrani
infect
newborn
mice
aaronson
et
al
latter
prove
sensit
method
isol
live
viru
brain
tissu
versu
posit
cell
cultur
newborn
mice
inocul
respect
tabl
thu
veev
consid
highli
cytopath
viru
uniformli
lethal
suscept
unvaccin
mice
persist
brain
infect
anim
without
caus
clinic
enceph
mortal
day
follow
challeng
infect
chimer
alphavirusbas
vaccin
repres
critic
advanc
vaccin
develop
number
infecti
pathogen
sindbi
replicon
particl
shown
safe
effect
induct
cellmedi
humor
immun
respons
davi
et
al
result
previous
publish
studi
paessler
et
al
paessler
et
al
confirm
safeti
sindbisve
virus
outbr
inbr
adult
mice
nih
swiss
vast
major
adult
immunodefici
mice
surviv
tcr
tcrand
mice
surviv
ko
mice
test
surviv
vaccin
develop
leukopenia
fever
hypothermia
result
challeng
prevail
paradigm
penetr
cn
highlevel
replic
veev
brain
lead
lethal
virusinduc
enceph
mous
model
result
present
indic
preimmun
veevinfect
anim
toler
rel
high
level
viral
replic
brain
without
appar
clinic
diseas
eg
enceph
paralysi
indic
mechan
host
respons
infect
may
addit
play
pivot
role
previou
studi
suggest
product
neutral
antibodi
critic
protect
enceph
caus
alphavirus
griffin
et
al
like
due
potenti
augment
clearanc
extracellular
viru
vaccin
mice
helper
cell
cell
shown
play
import
role
protect
bennett
et
al
report
neutral
antibodi
elicit
vaccin
attenu
sindbisve
viru
anim
depend
part
loss
adapt
immun
function
howev
detect
level
serum
neutral
antibodi
requir
surviv
demonstr
use
tcrdefici
mice
mice
mice
although
neutral
antibodi
promot
protect
lethal
enceph
essenti
switch
factor
anticip
igg
isotyp
predominantli
induc
result
vaccin
sindbisveev
chimera
snapper
paul
prior
studi
vsv
shown
neutral
reduc
neutral
igg
antibodi
maloy
et
al
seri
studi
tcrdefici
mice
produc
igg
neutral
antibodi
result
compens
cellderiv
similar
mechan
may
initi
respons
veev
cn
could
account
reduct
neutral
antibodi
tcrdefici
mice
mice
minor
proport
mice
surviv
infect
follow
vaccin
wherea
vaccin
tcrdefici
mice
uniformli
die
adopt
transfer
cell
vaccin
wt
donor
mice
result
reconstitut
protect
tcrdefici
mice
suggest
predomin
role
cell
type
paessler
unpublish
observ
studi
address
role
nonneutr
antibodi
may
produc
result
vaccin
andor
viral
challeng
previous
shown
prophylact
passiv
transfer
nonneutr
monoclon
antibodi
anim
infect
neuroadapt
sindbi
viru
caus
enceph
experiment
condit
prolong
surviv
protect
mice
complet
schmaljohn
et
al
howev
efficaci
differ
nonneutr
antibodi
describ
schmaljohn
et
al
correl
attenu
cn
infect
reflect
dramat
millionfold
reduc
viral
titer
brain
infect
treat
mice
comparison
infect
untreat
mice
led
hypothesi
host
cell
infect
block
via
either
two
altern
mechan
antibodydepend
cytolysi
infect
cell
ii
hindranc
viru
bud
infect
cell
bind
viral
protein
embed
membran
infect
cell
schmaljohn
et
al
similar
result
experiment
work
sindbi
viru
hunt
et
al
demonstr
protect
nonneutr
antibodi
amino
terminu
trinidad
donkey
strain
veev
base
abil
limit
viru
replic
brain
infect
mice
therebi
reduc
viral
load
brain
hunt
et
al
hunt
et
al
evalu
brain
studi
viral
load
reduc
vaccin
wt
mice
strain
select
immun
defici
equal
suscept
veev
replic
brain
regardless
outcom
infect
base
data
seroconvers
measur
preand
postchalleng
believ
humor
immun
respons
highli
limit
mice
select
immun
defici
robust
wt
mice
nevertheless
specul
import
nonneutr
antibodi
model
subsequ
studi
may
need
address
issu
studi
demonstr
protect
measur
surviv
vaccin
mice
rel
mockvaccin
control
may
complet
depend
presenc
detect
level
viru
neutral
antibodi
serum
role
virusspecif
cell
confirm
restor
protect
use
adopt
transfer
donor
cell
fig
vaccin
efficaci
mous
model
immunohistochem
analysi
brain
sinzpcor
mockvaccin
veevchalleng
mice
viral
antigen
brain
repres
photomicrograph
obtain
immunohistolog
analysi
brain
femal
chimer
sinzpc
virusor
mockvaccin
mice
euthan
day
follow
virul
veev
challeng
infect
describ
fig
characterist
parent
mice
wild
type
wt
immunodefici
mice
describ
materi
method
tabl
local
viral
antigen
reddishbrown
demonstr
via
immunostain
brain
section
use
antibodi
veev
atcc
cat
number
veev
antibodi
detect
use
biotinyl
secondari
antibodi
follow
avidinperoxidas
color
develop
slide
counterstain
mayer
modifi
hematoxylin
prior
mount
microscopi
wt
unvaccin
b
wt
chimer
sinzpcvaccin
follow
chimer
sinzpcvaccin
immunodefici
mice
c
tcr
ko
mice
e
tcr
ko
viral
antigen
detect
associ
neuron
cell
brain
stem
c
hippocampu
cortex
e
vaccin
wt
donor
mice
tcrdefici
recipi
furthermor
rel
degre
immunemedi
inflamm
tcrversu
tcrdefici
mice
fulli
correl
viral
clearanc
remark
vaccin
tcrdefici
mice
protect
lethal
intranas
viral
challeng
rel
wt
mice
veev
persist
brain
day
follow
inocul
viru
clearanc
affect
wt
inbr
outbr
mice
surviv
anim
lack
function
receptor
demonstr
lack
detect
infecti
viru
tabl
semiquantit
analysi
brain
patholog
viral
antigen
distribut
wild
type
immunodefici
mice
mice
immun
chimer
sinzpc
viru
plaqueform
unit
pfu
pb
pb
alon
mock
day
day
via
subcutan
rout
challeng
day
intranas
pfu
per
anim
pb
anim
sacrif
day
postchalleng
organ
harvest
histopatholog
analysi
histopatholog
score
normalneg
focal
spot
dissemin
sever
nd
done
asterisk
indic
parent
mice
wild
type
wt
characterist
immunodefici
mice
describ
materi
method
tabl
fig
vaccin
efficaci
mous
model
immunohistochem
analysi
brain
sinzpcand
mockvaccin
veevchalleng
mice
b
cell
brain
brain
harvest
mice
obtain
follow
vaccin
challeng
experi
describ
fig
characterist
parent
mice
wild
type
wt
immunodefici
mice
describ
materi
method
tabl
brain
anim
surviv
day
infect
data
demonstr
distinct
differ
vaccin
challeng
adapt
respons
neurovirul
veev
vs
tcell
defici
mice
thu
tcrbear
cell
appear
strictli
requir
protect
tcrbear
cell
may
possibl
persist
indirect
effect
deficit
cell
help
b
cell
latter
mice
futur
studi
examin
cell
type
respons
protect
role
cytolyt
cell
respons
veev
infect
clearli
defin
previou
studi
demonstr
signific
degre
variabl
depend
upon
viru
andor
mous
strain
test
jone
et
al
neuron
highli
prolif
believ
regener
mechan
viral
elimin
neuron
remain
intens
studi
focu
nonlyt
lytic
mechan
viral
clearanc
cell
shown
perform
redund
function
extent
involv
immun
respons
may
highli
depend
upon
cell
type
recruit
site
viral
replic
cn
peripheri
fig
vaccin
efficaci
mous
model
immunohistochem
analysi
brain
sinzpcand
mockvaccin
veevchalleng
mice
cell
brain
brain
harvest
mice
obtain
follow
vaccin
challeng
experi
describ
fig
characterist
parent
mice
wild
type
wt
immunodefici
mice
describ
materi
method
tabl
cell
detect
stain
antibodi
cell
marker
counterstain
mayer
modifi
hematoxylin
prior
mount
microscopi
describ
materi
method
cell
reddishbrown
shown
brain
follow
anim
wt
mockvaccin
day
postinfect
dpi
b
wt
chimer
sinzpcvaccin
dpi
follow
vaccin
immunodefici
mice
c
tcr
ko
dpi
tcr
ko
dpi
e
tcr
ko
dpi
f
higher
magnif
imag
panel
e
shown
note
protect
lethal
veev
infect
infect
mice
entir
correl
clearanc
infecti
viru
brain
howev
protect
posit
correl
accumul
cellular
infiltr
around
vasculatur
brain
routin
observ
lower
level
cellular
infiltr
morpholog
differ
inflammatori
foci
brain
tcrdefici
mice
thu
surviv
appear
enhanc
increas
level
inflamm
brain
earli
cours
infect
result
support
studi
cell
subset
eg
cell
clearanc
mechan
enabl
us
refin
understand
relationship
encephalit
veev
invas
replic
brain
clinic
outcom
vaccinationchalleng
studi
surpris
result
studi
cell
defici
mice
toler
high
level
viral
replic
first
day
infect
acut
phase
indistinguish
observ
unvaccin
mice
becam
paralyz
die
ii
lower
level
viru
persist
extend
period
time
asymptomat
persist
phase
observ
group
infecti
viru
persist
brain
despit
moder
level
inflamm
cellular
infiltr
site
infect
observ
histopatholog
evalu
brain
tissu
persist
infecti
veev
heretofor
describ
although
viral
rna
detect
brain
mice
surviv
acut
sindbi
viru
infect
levin
griffin
natur
persist
veev
cell
defici
mice
occur
absenc
clinic
diseas
interest
find
warrant
molecular
pathogenesi
studi
result
suggest
potenti
novel
role
cell
cn
tcr
shown
impact
cell
develop
pennington
et
al
howev
studi
tcrdefici
mice
surviv
lethal
veev
challeng
dose
gener
tcrdefici
mice
increas
suscept
tumor
exagger
immunopatholog
bacteri
infect
model
mukasa
et
al
function
produc
cell
shown
play
role
product
neutral
antibodi
respons
mice
vesicular
stomat
viru
vsv
maloy
et
al
respons
vaccin
challeng
veev
major
tcrdefici
mice
mount
detect
neutral
antibodi
respons
immunoregulatori
potenti
tcrbear
cell
divers
potenti
regul
cellular
infiltr
retent
site
inflamm
posit
neg
regul
effector
cell
function
includ
cytotox
directli
lyse
antigenpres
cell
block
influx
neutrophil
experiment
model
autoimmun
encephalomyel
cell
shown
promot
downmodul
inflammatori
respons
induc
turnov
encephalitogen
cell
via
mechan
ponomarev
dittel
interestingli
regul
appear
occur
late
diseas
process
may
involv
crosstalk
tcrbear
cell
precis
basi
specif
hostpathogeninteract
respons
clearanc
infecti
viru
select
viral
variant
unclear
occur
microenviron
extens
inflammatori
necrot
respons
particular
model
result
contrast
previous
publish
role
tcrbear
cell
encephalit
sindbi
viru
model
anim
defici
cell
lower
mortal
rate
infect
neuroadapt
sindbi
viru
indic
differ
contribut
outcom
brain
infect
rowel
griffin
recent
studi
orthopox
viru
infect
shown
key
role
cellderiv
innat
immun
infect
coronaviru
infect
human
cell
display
antisarscov
activ
abl
directli
kill
sarscovinfect
target
cell
gammadelta
cell
also
mediat
demyelin
athym
mice
infect
neurotrop
coronaviru
mous
hepat
viru
dandekar
et
al
process
shown
depend
product
result
contrast
alphavirusmedi
immun
veev
appear
partial
independ
signal
partial
independ
cell
earli
antivir
respons
data
indic
tcrbear
cell
may
stringent
requir
protect
current
addit
passiv
transfer
studi
ongo
defin
role
specif
cell
type
protect
sequenc
persist
virus
isol
vaccin
challeng
tcrdefici
mice
reveal
sever
genet
chang
present
irrespect
isol
method
studi
aim
character
genotyp
phenotyp
persist
virus
ongo
believ
observ
describ
herein
provid
opportun
dissect
potenti
intervent
point
could
enabl
us
design
addit
studi
identifi
prognost
marker
correl
protect
enceph
vaccin
mice
follow
mice
use
studi
tabl
purchas
jackson
laboratori
bar
harbor
main
wild
type
wt
waterston
et
al
tcr
ko
strain
j
mice
defici
cell
mombaert
et
al
tcr
ko
strain
nih
swiss
mice
vaccin
describ
previous
paessler
et
al
paessler
et
al
brain
harvest
day
postchalleng
time
point
sagit
section
half
h
brain
collect
plaqu
assay
perform
vaccinatedchalleng
anim
proport
plaqu
posit
sampl
report
na
avail
asterisk
indic
parent
mice
wild
type
wt
characterist
immunodefici
mice
describ
materi
method
tabl
one
half
brain
suspend
media
plaqu
assay
perform
use
suspens
b
suckl
mice
inocul
brain
suspens
via
intracrani
rout
fig
vaccin
efficaci
singl
immun
model
protect
mediat
passiv
cell
transfer
sixweekold
femal
tcrdefici
mice
vaccin
day
medial
thigh
chimer
sinzpc
vaccin
dose
plaqu
form
unit
pfu
total
volum
pb
pb
alon
wt
mock
death
record
follow
intranas
challeng
virul
veev
dose
pfu
per
anim
ca
ld
pb
week
follow
initi
vaccin
asterisk
indic
parent
mice
wild
type
wt
characterist
immunodefici
mice
describ
materi
method
tabl
bc
recipi
tcrdefici
mice
n
inject
day
via
intraperiton
rout
cell
isol
describ
materi
method
suspend
steril
phosphatebuff
salin
pb
control
reconstitut
experi
five
mice
inocul
pb
alon
recipi
mice
immun
chimer
sinzpc
day
cell
transfer
challeng
virul
veev
pfuanim
day
follow
immun
anim
monitor
death
indic
due
hurrican
rita
evacu
experi
shown
prematur
termin
day
postchalleng
j
mice
defici
cell
itohara
et
al
strain
j
matur
b
celldefici
kitamura
et
al
mice
ko
strain
j
homozyg
interferongamma
receptor
alpha
chain
chaindisrupt
mice
huang
et
al
mice
syrian
golden
hamster
mesocricetu
auratu
purchas
harlan
indianapoli
indiana
hous
specif
pathogenfre
environ
minimum
day
immun
immun
studi
carri
challeng
studi
anim
procedur
approv
institut
anim
care
use
committe
univers
texa
medic
branch
carri
accord
nih
guidelin
measur
bodi
temperatur
anim
anaesthet
isofluran
implant
subcutan
bmd
transpond
chip
purchas
bio
medic
data
system
inc
bmd
seaford
delawar
use
trocar
needl
assembl
anim
monitor
sign
infect
migrat
transpond
prior
temperatur
record
chip
scan
use
transpond
reader
bmd
download
digit
temperatur
data
perform
accord
manufactur
protocol
chimer
alphaviru
sinzpc
construct
encod
replic
machineri
sindbi
sin
viru
structur
gene
virul
veev
strain
describ
previous
paessler
et
al
infecti
viru
immun
mice
obtain
electropor
cell
viral
rna
transcript
obtain
driven
vitro
transcript
reaction
util
rna
polymeras
invitrogen
viru
harvest
develop
cytopath
effect
cpe
usual
h
follow
electropor
bredenbeek
et
al
immun
challeng
virul
veev
strain
safeti
studi
eleven
eighteenweekold
femal
mice
inocul
day
day
subcutan
sc
medial
thigh
chimer
sinzpc
viru
dose
pfu
total
volum
intranas
ident
dose
virul
veev
pb
pb
alon
mock
death
record
daili
telemetr
monitor
bodi
temperatur
perform
period
day
begin
day
prior
first
vaccin
day
efficaci
studi
immun
challeng
virul
veev
perform
accord
previous
establish
protocol
follow
mice
inocul
day
subcutan
sc
medial
thigh
chimer
sinzpc
viru
dose
plaqueform
unit
pfu
total
volum
pb
anim
receiv
addit
booster
day
unless
state
differ
use
ident
rout
dosag
first
immun
anim
bled
day
initi
immun
serum
sampl
collect
centrifug
heatinactiv
min
store
serolog
test
perform
day
day
follow
second
immun
mice
challeng
intranas
pfu
virul
veev
per
anim
pb
mice
observ
twice
daili
period
day
clinic
ill
anorexia
andor
paralysi
andor
death
chimer
sinzpc
vaccin
mice
three
anim
per
experiment
group
sacrif
day
brain
peripher
tissu
lung
liver
spleen
kidney
collect
viral
titrat
histolog
examin
immunohistochemistri
stain
day
postchalleng
anim
sacrif
organ
collect
mockvaccin
anim
two
day
three
day
mice
sacrif
viral
titrat
statist
analysi
surviv
group
period
perform
use
logrank
test
signific
level
b
graphpad
prism
san
diego
ca
statist
comparison
vaccin
mice
strain
comparison
mock
vaccin
wt
mice
perform
use
fisher
exact
test
signific
level
b
prism
cell
isol
immun
donor
mice
lambert
et
al
approxim
day
last
immun
chimer
sinzpc
briefli
thirti
donor
spleen
remov
singl
cell
suspens
gener
mechan
disrupt
splenocyt
fraction
lympholytem
accord
manufactur
protocol
accur
chemic
westburi
ny
cell
wash
three
time
mac
buffer
phosphat
buffer
salin
ph
supplement
bovin
serum
albumin
bsa
mm
edta
cell
separ
magnet
sortingbas
neg
select
accord
manufactur
instruct
automac
miltenyi
biotec
auburn
ca
puriti
confirm
cell
surfac
stain
flow
cytometr
analysi
prior
adopt
transfer
cell
tube
incub
min
ice
block
buffer
bsa
incub
min
hamster
antimous
antibodi
pharmingen
san
jose
ca
cell
wash
hamster
antimous
antibodi
bd
pharmingen
san
jose
ca
ad
cell
incub
min
cell
wash
fac
buffer
fix
formaldehyd
fluorescenceactiv
cell
sort
fac
analysi
acquisit
data
perform
facscan
flow
cytomet
becton
dickinson
san
jose
ca
data
collect
analyz
cellquest
softwar
becton
dickinson
san
jose
ca
tlymphocyt
popul
gate
base
forward
side
scatter
express
least
lymphocyt
acquir
analysi
alphabeta
tcrdefici
mice
recipi
n
inject
day
via
intraperiton
rout
cell
obtain
sinzpc
immun
wt
donor
describ
cell
subset
isol
suspend
steril
phosphatebuff
salin
pb
control
reconstitut
experi
five
mice
inocul
pb
alon
recipi
mice
immun
chimer
sin
zpc
day
cell
transfer
challeng
virul
veev
day
follow
immun
describ
immun
challeng
mice
viral
replic
brain
peripher
organ
assess
plaqu
assay
mous
organ
eg
brain
lung
liver
spleen
kidney
collect
day
postchalleng
sagitt
section
half
one
half
brain
homogen
mem
contain
fb
suspens
made
organ
suspens
maintain
process
day
organ
titer
infecti
viru
calcul
use
plaqu
assay
previous
describ
paessler
et
al
anim
surviv
challeng
day
qualit
assay
infecti
viru
perform
histopatholog
histopatholog
analysi
brain
section
perform
neuropathologist
blind
sampl
identif
score
determin
indic
tabl
brain
fix
buffer
formalin
h
store
ethanol
h
sampl
embed
paraffin
section
mount
slide
standard
hematoxylin
eosin
h
e
stain
perform
viral
antigen
stain
mous
veevspecif
hyperimmun
serum
rais
everglad
viru
member
vee
complex
atcc
cat
number
appli
dilut
pb
brain
section
min
normal
mous
serum
igreadytousekit
dakocytom
cat
use
neg
control
antibodi
brain
infect
mice
brain
section
agematch
uninfect
mice
use
neg
control
tissu
immunostain
histomousesp
kit
zyme
cat
use
detect
mous
antibodi
mous
tissu
slide
counterstain
mayer
modifi
hematoxylin
microscopi
babi
hamster
kidney
cell
line
kindli
provid
dr
paul
olivo
washington
univers
st
loui
mo
maintain
alpha
minimum
essenti
medium
supplement
fetal
bovin
serum
fb
vitamin
plaqu
reduct
neutral
test
prnt
perform
monolay
briefli
stock
chimer
sinzpc
viru
incub
h
differ
dilut
sera
taken
individu
infect
mice
subsequ
cell
monolay
incub
viru
serum
mixtur
h
overlaid
agaros
maintain
h
stain
crystal
violet
beati
et
al
serum
dilut
correspond
endpoint
plaqu
reduct
determin
